NFSCF — Enphys Acquisition Balance Sheet
0.000.00%
- $135.64m
- $136.87m
- 59
- 31
- 51
- 44
Annual balance sheet for Enphys Acquisition, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | 10-K | 10-K | 10-K | |
Standards: | — | USG | USG | USG |
Status: | fx Preliminary | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | — | 0.811 | 0.273 | 0.113 |
Net Total Receivables | — | 0.1 | 0 | — |
Prepaid Expenses | ||||
Total Current Assets | — | 1.19 | 0.474 | 0.156 |
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | — | 346 | 351 | 109 |
Accounts Payable | ||||
Payable / Accrued | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Current Liabilities | — | 0.24 | 0.255 | 1.12 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | — | 25.3 | 14.7 | 14.5 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | — | 321 | 336 | 94.6 |
Total Liabilities & Shareholders' Equity | — | 346 | 351 | 109 |
Total Common Shares Outstanding |